The other eight types of cancers with upregulated PRR11 include bladder urothelial carcinoma (BLCA), cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), cholangio carcinoma (CHOL), esophageal carcinoma (ESCA), glioblastoma multiforme (GBM), pheochromocytoma and paraganglioma (PCPG), rectum adenocarcinoma (READ), and sarcoma (SARC) (Supplementary Figure S2). Here, PRR11 is linked to bladder transitional cell carcinoma.